# Intravenous Iron Metabolism in Restless Legs Syndrome

> **NCT00685815** · PHASE2 · COMPLETED · sponsor: **American Regent, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Restless Legs

## Interventions

- **DRUG:** Ferric Carboxymaltose (FCM)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00685815
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2010-12
- **Final completion:** 2012-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685815, "Intravenous Iron Metabolism in Restless Legs Syndrome". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00685815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*